Monday, April 21, 2014

 

 



Soy un nuevo usuario

Olvidé mi contraseña

Entrada usuarios

Lógica Matemáticas Astronomía y Astrofísica Física Química Ciencias de la Vida
Ciencias de la Tierra y Espacio Ciencias Agrarias Ciencias Médicas Ciencias Tecnológicas Antropología Demografía
Ciencias Económicas Geografía Historia Ciencias Jurídicas y Derecho Lingüística Pedagogía
Ciencia Política Psicología Artes y Letras Sociología Ética Filosofía
 

rss_1.0 Otros recursos con las palabras clave Rheumatoid arthritis

Resultados 1 - 10 de 768 de Rheumatoid arthritis. (0,02 segundos)

Documentos:
1. (�) Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung Diseases. - Saketkoo, LA; Mittoo, S; Frankel, S; Lesage, D; Sarver, C; Phillips, K; Strand, V; Matteson, EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group,; Delphi Process Collaborators,
Interstitial lung diseases (ILD), including those related to connective tissue disease (CTD), and id ...
- 11-abr-2014

2. (�) Open Rheumatology Journal
- 06-abr-2014

3. (�) Expanded population of CD1d-restricted Vα24(+) cells in a patient with active rheumatoid arthritis. - Gutowska-Owsiak, D; Birchall, MA; Moots, RJ; Christmas, SE; Pazmany, L
- 26-mar-2014

4. (�) Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis. - de Souza, TR; de Albuquerque Tavares Carvalho, A; Duarte, AP; Porter, SR; Leão, JC; Alcino Gueiros, L
Sjogren's syndrome is characterized by T-cell infiltration of exocrine glands leading to parenchymal ...
- 23-mar-2014

5. (�) B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. - Rapetti, L; Chavele, KM; Evans, CM; Ehrenstein, MR
To investigate whether regulatory T cells (Treg) can control B cell function in rheumatoid arthritis (RA) and if not to explore the basis for this defect.
- 23-mar-2014

6. (�) Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis - Gracia Villa, María de; Jiménez-Jorquera, Cecilia; Haro Villar, Isabel; Gómara Elena, María José; Sanmartí, Raimon; Fernández-Sánchez, César; Mendoza Gómez, Ernest
), which are specific for rheumatoid arthritis (RA) autoimmune disease. Sera of RA patients contain
- 27-feb-2014

7. (�) Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis - Xie, Gang; Lu, Yue; Sun, Ye; Zhang, Steven Shiyang; Keystone, Edward Clark; Gregersen, Peter K; Plenge, Robert M; Amos, Christopher I; Siminovitch, Katherine A
Objective: To fine-map the NF-κB activating protein-like (NKAPL) locus identified in a prior genome-wide study as a possible rheumatoid arthritis (RA) risk locus and thereby delineate additional
- 15-feb-2014

8. (�) Tolerizing DNA vaccines for autoimmune arthritis - Peggy P. Ho; John P. Higgins; Brian A. Kidd; Beren Tomooka; Carla Digennaro; Lowen Y. Lee; Henry E. Neuman De Vegvar; Lawrence Steinman; William H. Robinson
Current therapies for rheumatoid arthritis (RA) and other autoimmune diseases non-specifically ... to treat collagen-induced arthritis (CIA) in mice, and use of protein microarrays to monitor
(application/pdf) - 02-feb-2014

9. (�) Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis. - Paula, F; Alves, J
spondylitis and psoriatic arthritis, this treatment seems to be even more effective than in rheumatoid ...), etanercept (Enbrel), and adalimumab (Humira), are approved for the treatment of rheumatoid arthritis in
- 30-ene-2014

10. (�) Author manuscript, published in "Ann Rheum Dis 2009;68(8):1328-33" DOI: 10.1136/ard.2008.093153 Apolipoprotein A-I and platelet factor 4 are biomarkers for Infliximab response in Rheumatoid Arthritis - Ice Trocmé; Hubert Marotte (md; Athan Baillet; Béatrice Pallot; Inserm U; Chu Hôpital Michallon; Grenoble France; Gaudin Md
Objectives: The use of biologics such as infliximab has dramatically improved the treatment of rheumatoid arthritis (RA). However, factors predictive of therapeutic response need to be identified
(application/pdf) - 29-ene-2014

Página de resultados:
 

Busque un recurso